장마감
Log in Sign up
LFSC
LFSC
F/m Emerald Life Sciences Innovation ETF
7월 28일 4:00 PM ET (한국 7/29 05:00)
$45.37
+0.08 ▲ +0.18%
🌙 7월 28일 7:34 PM ET (한국 7/29 08:34)
$45.19
-0.21 ▼ -0.46%

LFSC ETF is analyzed across 10 metrics including expense ratio, holdings, sector allocation, dividends, RSI, and MACD.

시황 · 실적발표 · 매수매도 신호, 가장 먼저 받아보세요 🔔 구독
Total Expense Ratio
0.54%
Annual operating cost
Net Assets (AUM)
$124M
약 1696억원
Holdings
39 items
Dividend Yield
-
Management Style
Active
Category US Equities - Industry SectorAsset Type Equities (Stocks)Return% 1Y 83.01%Total Holdings 39Perf Week -1.02%
ETF Type US EquitiesActive/Passive ActiveReturn% 3Y -AUM $124MPerf Month 0.89%
Expense 0.54%NAV $45.24Return% 5Y -52W High -4.84%Perf Quarter 20.53%
Dividend TTM -Div Gr. 3/5Y -Return% 10Y -52W Low 87.29%Perf Half Y 25.45%
Flows% 1M 1.51%Flows% YTD 6.93%Return% SI 41.14%Volatility(W/M) 1.2% 1.77%Perf YTD 23.91%
SMA20 -0.76%SMA50 7.58%SMA200 21.8%RSI (14) 55.31Beta 0.93
IPO 2024/10/31Prev Close $45.29Perf Year 86.11%Avg Volume 0.00MPrice $45.37

📊 F/m Emerald Life Sciences Innovation ETF (LFSC) Investment Analysis

ETF Overview

F/m Emerald Life Sciences Innovation ETF · US Equities - Industry Sector

액티브 운용 — 펀드매니저가 종목을 선별해 초과수익 추구
2024년 상장, 2년 운영 중.

F/m Emerald Life Sciences Innovation ETF는 장기 자본 증식을 목표로 합니다. 액티브 운용 ETF이며, 운용사 감독 하에 하위 자문사 Emerald Mutual Fund Advisers Trust가 선정한 생명과학 기업의 주식 증권에 주로 투자합니다. 통상적인 시장 여건에서 순자산의 최소 80%를 혁신을 보이는 생명과학 기업의 주식 증권에 투자합니다.

📘 LFSC ETF 자세히 알아보기 →
Developedequityinnovationhealthcare
규모
$124M 약 1696억원
운용사
F/m Investments
운용 방식
액티브 (운용사 재량)
상장일
2024년

Cost Efficiency

Annual Expense Ratio · Category Rank · Long-Term Cost Impact

Average expense ratio — 0.54% annually
Mid-range within the US Equities - Industry Sector category.
Effective Annual Expense Ratio (Net Expense Ratio)
평균권
0.54%
My positionMid-range
Low range Average High range
Actual Cost Simulation by Investment Amount
$100.0M
Annual Expense Ratio
$540K
Pay $40K more per year vs. category average
Category Median Annual Cost
$500K
Based on expense ratio of 0.50%
10-Year Cumulative Expense Ratio (Long-term simulation assuming 7% annual market growth)
$9.7M
10.0% of returns you could have earned goes to the fund manager due to fees
💡 Because the expense ratio takes a slice of your assets every year, costs compound over 10 years and result in far greater losses than a simple sum (annual fee × 10). The 7% annual return assumption is based on the S&P 500's long-term average.

Defaults shown against $100K baseline portfolio. Adjust the slider to update the amount in real time.

Cheaper alternatives in the same category

* A lower fee does not necessarily mean a better ETF. Consider the tracked index, liquidity, and tax treatment as well.

Long-Term Performance

1-year · 3-year · 5-year · 10-year returns · vs. benchmark · drawdown defense

Insufficient return data
+65.2%p vs. benchmark (SPY) over 1Y.
ℹ️ The "1Y·3Y·5Y·10Y" periods below represent annualized returns (CAGR) measured backward from today. Example: "3Y +12%" means the investment grew at a compounded 12% per year over the past three years.
If you had invested 1 year(s) ago
$100.0M
Today's value
$183.0M
Total gain
+$83.0M
Annualized +83.0%
1 Year
2025.07 ~ 2026.07
Annualized +83.01%
상위 5%
Outperformed the benchmark by 65.2%p annually
My positionTop 5%
Low range Average High range
3 Years
2023.07 ~ 2026.07
Listed 2024/10 — under 3 years
5 Years
2021.07 ~ 2026.07
Listed 2024/10 — under 5 years
10Y
2016.07 ~ 2026.07
Listed 2024/10 — under 10 years
2Y Cumulative Total Return Curve
2024-10-31 start, based on a 100M KRW base — read the curve values directly as units of 100M KRW (e.g., 308 → 3.08억 / 308M KRW). Both this ETF and the benchmark are rebased to 100 on the same start date for comparison.
LFSC · Price Only LFSC · Price + Cumulative Dividends LFSC · Dividend Reinvested S&P 500 (SPY)
50
100
150
200
ℹ️ Price Only: Excludes dividends and tracks pure stock price only. Covered-call and high-dividend ETFs often show a flat or declining line on this view, which is meaningful from a "principal preservation" standpoint. Price + Cumulative Dividend: Share count stays the same and received dividends are accumulated as cash. Closely matches your actual account total assets. Reinvested: Dividends are immediately used to buy additional shares (adjClose-based, the industry standard for total return). The wider the gap between the three lines, the easier it is to gauge the effectiveness of the dividend strategy.
Annual Return Comparison
ETF returns vs S&P 500 (SPY) by calendar year
LFSC S&P 500 (SPY)
+60%
0%
−60%
-6%
2024
+54%
2025
+25%
2026 YTD
ℹ️ Returns from January 1 to December 31 of each year. The current year (2026) column is dimmed to indicate YTD (incomplete). If blue is higher than gray, the ETF outperformed the benchmark in that year.
Win rate vs S&P 500 (SPY)
Completed years: 2 — 3+ years of data are needed for a win rate to be shown.
2024
2025
2026 YTD
ℹ️ Number of winning years versus S&P 500 (SPY) within a completed calendar year (1/1–12/31). The current year (YTD) is reported separately.
Downside Capture
⚖️ 102%
Falls in line with the benchmark — high correlation
<85% (Defend) 85~110% (Track) >110% (Lag)
ℹ️ Average % drop of this ETF when S&P 500 (SPY) is −1%. Based on daily returns over the past 3 years (only days where the benchmark is negative).

Risk Profile

Volatility · Beta · Max Drawdown · Sharpe · Drawdown Recovery History

Overall Risk Grade
Low Risk
Less volatile than the market average, making it relatively easy to hold over time.
Beta (market sensitivity)
평균권
0.93
If the market rises +10% +9.3%
If the market falls -10% -9.3%
My positionMid-range
Low range Average High range
ℹ️ A beta of 1.0 moves in line with the market. Above 1 means it moves more than the market; below 1 means less.
Average daily range (last 1 month)
평균권
±1.77%
S&P 500 typically ±1.0~1.3% · Bond funds ±0.3% · Leveraged ETFs ±3% or more
Annual volatility trend (past 10 years)
ℹ️ This ETF's average daily price swing. 1% means "on average, moves about ±1% per day." The rolling curve below shows the annualized volatility (long-term standard measure) over time.
Max Drawdown · Past 10 years
-29.7%
Drawdown duration: 5 months
2024-11-11 → 2025-04-08
Recovered in about 5 months
2024-10-31 Worst -20% 2026-07-01
ℹ️ Maximum drawdown is the largest peak-to-trough decline in the past. It represents the worst-case loss a long-term investor must psychologically endure.
Sharpe Ratio (Risk-Adjusted Return)
1.33
Good — Solid risk-adjusted returns
ℹ️ Annualized return minus the risk-free rate (3% annualized), divided by annualized volatility. A value above 1.0 is generally considered good risk-adjusted performance.

Overall investment appeal

What this ETF fits best — strengths, weaknesses, and target investor profile

Strengths and weaknesses both present Check the fit below to see whether it matches your investing goal.
🎯 목적별 적합도
내가 이 ETF를 어떤 목적으로 활용할 수 있는지 확인하세요.
🌳
장기 보유
수년 이상 꾸준히 모아갈 때
보통
💵
배당 인컴
매월·분기 현금흐름이 목적일 때
낮음
단기 트레이딩
며칠~몇 주 단기 방향성 매매
낮음
🧩
포트폴리오 보조
자산 배분·헤지 용도
낮음
👤
이런 분에게 어울려요
Investors who believe in active strategies
✅ 강점
  • 🎯Outperforms benchmark by +65.2%p annually
⚠️ 약점·주의사항
특별한 약점이 보이지 않아요.

Portfolio Composition

What's actually inside — sector weights and top holdings

40개 종목에 넓게 분산
개별 종목 리스크가 분산되어 있어요.
ℹ️ 왜 구성을 봐야 하나요?
ETF의 실제 성과는 담고 있는 종목과 섹터에서 나와요. 이름이 "S&P 500"이라도 기술주 비중이 유난히 높을 수 있고, "배당주 ETF"라도 몇몇 대형주에 쏠려 있을 수 있어요. 라벨보다 실제 구성을 확인하는 게 중요해요.
🔬 집중도 한눈에 보기
총 보유종목
40개
상위 10개 비중
52.5%
최대 단일 종목
9.05%
집중도(HHI)
400
낮음 (분산)
⚠️ 소수 종목·섹터에 집중되어 있어, 해당 종목/섹터가 흔들리면 ETF 전체가 크게 영향을 받아요.
🥧 섹터 비중
90%Healthcare
Healthcare
90.3%
📋 상위 보유 종목 Top 10 Top 10이 전체의 52.5% 차지
티커 옆의 점 색상 = 섹터 구분 (섹터 차트와 동일 색상)
#1 COGT COGT Cogent Biosciences Inc
9.05%
#2 LIVN LIVN LivaNova PLC
7.36%
#3 TMDX TMDX TransMedics Group Inc
5.26%
#4 MIRM MIRM Mirum Pharmaceuticals Inc
4.84%
#5 TVTX TVTX Travere Therapeutics Inc
4.63%
#6 SYRE SYRE Spyre Therapeutics Inc
4.41%
#7 UTHR UTHR United Therapeutics Corp
4.35%
#8 GH GH Guardant Health Inc
4.32%
#9 WVE WVE WaVe Life Sciences Ltd
4.21%
#10 SVRA SVRA Savara Inc
4.04%

Category Peers

Category: US Equities - Industry Sector

같은 카테고리 6종 중 AUM 6/6위 · 보수율 2/6위
카테고리: US Equities - Industry Sector
ℹ️ 왜 비교해야 하나요?
같은 카테고리 ETF끼리는 보수율·규모(AUM)·배당률을 비교해 볼 가치가 있어요. 보수율은 낮을수록 장기 수익에 유리하고, AUM이 크면 운용 안정성이 높아요. ▲ 표시LFSC보다 유리, ▼ 표시LFSC보다 불리를 뜻해요.
티커ETF명보수율AUM보유종목배당률YTD1년
LFSC LFSC
F/m Emerald Life Sciences Innovation ETF0.54% $124M 39- +23.91% +86.11%
Fundstrat Granny Shots US Large Cap ETF0.75% $4.3B 440.07% - +13.77%
Roundhill Magnificent Seven ETF0.3% $3.7B 241.54% - +9.00%
ARK Genomic Revolution ETF0.75% $1.6B 33- - +47.27%
State Street US Sector Rotation ETF0.7% $999M 260.47% - +13.61%
Day Hagan Smart Sector ETF0.77% $561M 170.46% - +17.45%
AUM 내림차순 정렬 · ▲ LFSC보다 유리 · ▼ LFSC보다 불리
📊
See the market at a glance with a real-time dashboard Track premarket, regular, and after-hours quotes, screeners, and heatmaps on a single screen

FAQ

What kind of ETF is LFSC?

LFSC is an ETF in the US Equities - Industry Sector category, managed by F/m Investments.

How many holdings does LFSC have?

LFSC holds a total of 39 securities, with an AUM of approximately $124M.

What is the 52-week high and low for LFSC?

LFSC has recorded a 52-week high of $47.68 and a low of $24.22.

시황 · 실적발표 · 매수매도 신호, 가장 먼저 받아보세요 🔔 구독

면책조항: 본 콘텐츠는 참고 자료이며 투자 권유가 아닙니다. 모든 투자의 책임은 투자자 본인에게 있습니다.